Allovir
Berkeley Heights, US · 13 employees on LinkedIn · 1 known investors
Kalaris Therapeutics is a clinical-stage biopharmaceutical company developing retinal disease treatments, specifically engineered biologics for wet AMD, diabetic eye disease, and retinal vein occlusion. The company focuses on reducing patient treatment burden through extended-duration therapies that require fewer clinic visits.
Founders & leadership
NF
Napoleone FerraraDirector & Co-Founder
SA
Srinivas AkkarajuDirector & Co-founder
MD
Mike DybbsDirector & Co-founder
Investors · 1
Frequently asked questions
- What does Allovir do?
- Kalaris Therapeutics is a clinical-stage biopharmaceutical company developing retinal disease treatments, specifically engineered biologics for wet AMD, diabetic eye disease, and retinal vein occlusion. The company focuses on reducing patient treatment burden through extended-duration therapies that require fewer clinic visits.
- Who founded Allovir?
- Allovir was founded by Napoleone Ferrara, Srinivas Akkaraju, Mike Dybbs.
- Who are Allovir's investors?
- Allovir's investors include EcoR1 Capital.
- Where is Allovir headquartered?
- Allovir is headquartered in Berkeley Heights, US.